Signaturefd LLC Invests $53,000 in Braskem S.A. (NYSE:BAK)

Signaturefd LLC bought a new stake in shares of Braskem S.A. (NYSE:BAKFree Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,687 shares of the company’s stock, valued at approximately $53,000.

Other hedge funds also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of Braskem by 876.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,427 shares of the company’s stock valued at $40,000 after buying an additional 4,871 shares during the last quarter. R Squared Ltd acquired a new stake in Braskem during the fourth quarter worth about $44,000. Blue Trust Inc. raised its position in Braskem by 2,510.3% during the fourth quarter. Blue Trust Inc. now owns 13,130 shares of the company’s stock valued at $51,000 after acquiring an additional 12,627 shares in the last quarter. HighTower Advisors LLC lifted its holdings in Braskem by 19.4% in the fourth quarter. HighTower Advisors LLC now owns 19,213 shares of the company’s stock valued at $74,000 after acquiring an additional 3,126 shares during the period. Finally, Virtu Financial LLC purchased a new stake in Braskem in the 3rd quarter worth approximately $88,000.

Analysts Set New Price Targets

Separately, Scotiabank cut shares of Braskem from a “sector outperform” rating to a “sector perform” rating in a research note on Monday, March 3rd.

Check Out Our Latest Report on BAK

Braskem Stock Down 3.3 %

Shares of Braskem stock opened at $3.63 on Tuesday. The firm has a market cap of $1.44 billion, a PE ratio of -1.02 and a beta of 2.06. The business has a 50-day moving average price of $4.23 and a 200 day moving average price of $5.12. Braskem S.A. has a twelve month low of $3.41 and a twelve month high of $10.91.

Braskem (NYSE:BAKGet Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.01). Braskem had a negative return on equity of 439.59% and a negative net margin of 9.88%. The business had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.52 billion. On average, sell-side analysts expect that Braskem S.A. will post -0.77 EPS for the current year.

Braskem Company Profile

(Free Report)

Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.

Recommended Stories

Want to see what other hedge funds are holding BAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Braskem S.A. (NYSE:BAKFree Report).

Institutional Ownership by Quarter for Braskem (NYSE:BAK)

Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.